New Drug Target Improves Memory in Mouse Model of Alzheimer’s Disease
March 7, 2012
…(AD) in an animal model representative of most AD patients.
March 7, 2012
…(AD) in an animal model representative of most AD patients.
November 30, 2023
MED-235 Tribal Ambulatory Health Care Experience is an elective course designed to provide medical students with the opportunity to observe physicians at the Indian Health Council to gain a better understanding of the provision of health care to Native American populations’ health.
May 12, 2022
…San Diego Health’s diverse patient population. This is accomplished through collaboration between UC San Diego Health and local community colleges in San Diego, including Southwestern Community College, City College and Grossmont Community College. “We recognized a disparity between diversity of our nursing staff and the patients we serve,” said Cabiria…
June 13, 2019
…Muscle cells from a patient with myotonic dystrophy type I, untreated (left) and treated with the RNA-targeting Cas9 system 〈right〉. The MBNL1 protein is in green, repetitive RNA in red and the cell’s nucleus in blue. MBNL1 is an important RNA-binding protein and its normal function is disrupted when it…
November 29, 2022
The Urology for Social Responsibility seminar will be offered in the T. Denny Sanford Center Medical Education and Telemedicine on the UC San Diego campus from January 14 to 15, 2023.
June 13, 2023
Loomba will lead the division at UC San Diego School of Medicine, building upon a team that shines a light on UC San Diego Health’s tripartite mission.
July 9, 2020
…through hospital units, seeing patients and learning on the job from physicians. Kim Parra-Guerrero (left), UC San Diego medical student, and her mother, who moved to the U.S. from Colombia “Suddenly, you’re not sitting at your desk, studying for 12 hours a day, and that can be a rough transition…
July 20, 2023
The ceremony recognized the work of individuals and teams whose improvement projects made a positive impact for providers, staff and patients at UC San Diego Health.
September 11, 2019
Ventrix, a University of California San Diego spin-off company, has successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims to repair damage and restore cardiac function in heart failure patients who previously suffered a heart attack.
November 20, 2018
Researchers at University of California San Diego School of Medicine with colleagues at the National Institutes of Health and UC San Francisco report finding infectious agent in the eyes of deceased sCJD patients, making the eye a potential source for early CJD detection and prevention of disease.